Related Experiment Video

Updated: Jun 10, 2026

Using Inducible Osteoblastic Lineage-Specific Stat3 Knockout Mice to Study Alveolar Bone Remodeling During Orthodontic Tooth Movement
05:25

Using Inducible Osteoblastic Lineage-Specific Stat3 Knockout Mice to Study Alveolar Bone Remodeling During Orthodontic Tooth Movement

Published on: July 21, 2023

Treatment options for thalassemia patients with osteoporosis

Evangelos Terpos1, Ersi Voskaridou

  • 1Department of Clinical Therapeutics, University of Athens School of Medicine, Athens, Greece. eterpos@hotmail.com

Annals of the New York Academy of Sciences
|August 18, 2010
PubMed

Insights

Osteoporosis is common in thalassemia due to factors like hormonal issues and iron overload. Bisphosphonates are emerging as a key treatment for bone loss by inhibiting bone resorption.

Area of Science:

  • Hematology
  • Endocrinology
  • Bone Metabolism

Background:

  • Osteoporosis is a significant complication in thalassemia patients.
  • Multiple factors contribute to bone loss, including hormonal imbalances, iron toxicity, and marrow expansion.
  • Current management involves hormonal replacement, iron chelation, and nutritional support.

Purpose of the Study:

  • To review the causes and current management of osteoporosis in thalassemia.
  • To highlight emerging therapeutic strategies for bone loss in this population.

Main Methods:

  • Literature review of pathogenetic mechanisms and therapeutic interventions for osteoporosis in thalassemia.
  • Analysis of recent data on bone remodeling in thalassemia patients.

Main Results:

  • Osteoporosis in thalassemia is multifactorial, involving impaired osteoblast function and increased osteoclast activity.
  • Established treatments address underlying causes but may not fully counteract bone resorption.
  • Emerging evidence suggests bisphosphonates, which inhibit osteoclast activation, are a promising therapeutic avenue.

Conclusions:

  • Osteoporosis management in thalassemia requires a comprehensive approach addressing hormonal, metabolic, and bone remodeling factors.
  • Bisphosphonates represent a significant advancement in treating thalassemia-associated osteoporosis by targeting increased bone resorption.

Related Concept Videos

Fractures: Bone Repair01:27

Fractures: Bone Repair

Treatment for a fracture is based on the type of break, the bone affected, and the patient's age.
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the procedure...
Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Role of Vitamins in Maintaining Bone Health01:25

Role of Vitamins in Maintaining Bone Health

The growth and maintenance of bone are regulated by a combination of nutritional factors, including vitamins, such as vitamin A, B12, C, D, and K.
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Bone Remodeling01:40

Bone Remodeling

Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.